PET/CT imaging for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new PET/CT imaging agent called INR202 to see if it can help find and assess advanced solid tumors. The scan may help doctors better understand your cancer and guide treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You should be able to take care of yourself and be up and about (ECOG score 0 or 1).
- You must have an advanced solid tumor (a cancer that has spread).
- Your main organs (kidneys, liver, bone marrow) should be working well enough to participate.
- You should have a life expectancy of at least 6 months.
- You must agree to use contraception (if you can have children) during the study and for 3 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This trial is testing a new imaging agent called RT01-89Zr to see if it can help detect solid tumors during PET/CT scans. It involves an injection of the agent followed by imaging, and may offer a more targeted way to visualize tumors.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It could help diagnose cancer or check if it has returned after treatment.
This trial tests a new type of PET scan (a special imaging test) called 89Zr-s-C1 to help detect and monitor solid tumors like melanoma, gastric cancer, or colorectal cancer. The scan may help doctors see tumors more clearly and track whether treatment is working.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.